Systemic lupus erythematosus (SLE or lupus) is a chronic disease that causes systemic inflammation and affects multiple organs. Who is most at risk to develop SLE, and why? How does a person transition from healthy to active lupus? How can we help patients achieve and maintain remission? These are some of the questions explored in sessions at ACR Convergence 2020.
Dozens of research abstracts on various aspects of lupus were presented during the fully virtual event, and David S. Pisetsky, MD, PhD, professor of medicine and immunology at Duke University School of Medicine in Durham, N.C., a staff rheumatologist at the Durham VA Medical Center and the very first physician editor of The Rheumatologist, highlighted a select few abstracts for us. “I have tried to highlight the context of the work and its importance,” he says.
Also, see below for TR Physician Editor Philip Seo, MD, MHS-selected coverage from ACR Convergence 2020. And we invite you to explore our collection of research reviews, case reports and clinical articles on advances in the diagnosis and management of SLE.
